Your monthly Trogarzo cost savings if eligible
With our assistance, you could access the Trogarzo patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Trogarzo patient assistance?
We review each Trogarzo enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Trogarzo patient assistance program?
Our process makes it as easy as possible to apply for the Trogarzo patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Trogarzo, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Trogarzo coupons provider?
NiceRx is not a Trogarzo coupon, Trogarzo discount card, or Trogarzo copay card provider. We do not offer Trogarzo manufacturer coupons, Trogarzo discounts, rebates, Trogarzo savings cards, trial offers, or free Trogarzo samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Trogarzo
- Your insurance company will not pay for your Trogarzo prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Trogarzo cost without insurance?
Without insurance, Trogarzo costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Trogarzo intravenous solution (200 mg/1.33 mL) will cost around $2,700 for a supply of 2.66 milliliters.
How much does Trogarzo cost with insurance?
The copay for Trogarzo will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Trogarzo?
Trogarzo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by TaiMed Biologics USA Corp. and distributed by Theratechnologies Inc.
Trogarzo is a CD4-directed post-attachment HIV-1 inhibitor and is used with other antiretroviral drugs for the treatment of human immunodeficiency virus type 1 (HIV-1) infections in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
The use of Trogarzo is likely to be reserved for rare instances when an adult has developed multiclass antiretroviral drug resistance to HIV treatment and for whom a complete regimen cannot be created from other options. Trogarzo is not a cure for HIV-1 infections or AIDS, but it may delay damage to the immune system and the development of infections and diseases associated with AIDS. Trogarzo will maintain baseline viral load suppression for nearly 10 years.
What doses of Trogarzo are available?
Trogarzo is available in injection form, in the following doses: 200 mg/1.33 mL (150 mg/mL) in a single-dose vial.
Trogarzo is given intravenously as an IV infusion. It is given as a single loading dose of 2,000 mg followed by a maintenance dose of 800 mg every 2 weeks, after dilution in 250 mL of 0.9% Sodium Chloride Injection, USP.
Please read the full prescribing information and safety information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Trogarzo active ingredients
The active ingredient of Trogarzo is ibalizumab-uiyk, an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body.
Ibalizumab-uiyk, a recombinant humanized monoclonal antibody, prevents HIV-1 from infecting CD4+ T cells by binding to domain 2 of CD4 and interfering with post-attachment steps needed for the entry of HIV-1 virus particles into host cells and preventing the viral transmission that occurs via cell-cell fusion.
Trogarzo side effects
The most common side effects of Trogarzo in clinical trials include:
In rare instances, Trogarzo can cause more serious adverse effects. These can include:
- Immune reconstitution inflammatory syndrome (IRIS) has been reported in patients treated with combination antiretroviral therapies
Your doctor will assess the benefits of using Trogarzo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Trogarzo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Trogarzo drug interactions
No data is currently available for interactions of Trogarzo with other medicines. Tell your doctor about all the medicines you take, including prescription drugs and over‑the‑counter medicines, vitamins, and herbal supplements.
You should not use Trogarzo if you:
- Are allergic to the active ingredient ibalizumab-uiyk
- Are allergic to any of the other ingredients in Trogarzo
- Are breastfeeding or are planning to breastfeed – do not breastfeed if you are receiving Trogarzo as it is not known if it is passed into breast milk
Talk to your doctor before using Trogarzo if you:
- Are taking any of the medications that could interact with Trogarzo
- Are pregnant or are planning to become pregnant – ibalizumab-uiyk is transported across the placenta as pregnancy progresses and has the potential to be transmitted from the mother to the developing fetus
Trogarzo is the trademark brand name for ibalizumab-uiyk manufactured by TaiMed Biologics USA Corp. and distributed by Theratechnologies Inc. A generic version of ibalizumab-uiyk is available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Trogarzo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.